NimaMosammaparastMDPhD
Pathology • Saint Louis, MOAnatomic Pathology, Clinical Pathology
Professor of Pathology and Immunology, and of Oncology, Washington University in St. Louis School of Medicine; Co-Director, DNA Metabolism & Repair Program, Siteman Cancer Center
Dr. Mosammaparast is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110Phone+1 314-362-5641Fax+1 314-362-0369
Summary
- Dr. Nima Mosammaparast is a pathologist in Saint Louis, MO. He received his medical degree from University of Virginia School of Medicine and has been in practice 11 years. He specializes in clinical pathology.
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Research, 2009 - 2011- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2006 - 2009
University of Virginia School of MedicineClass of 2006
Certifications & Licensure
IL State Medical License 2024 - 2026
MO State Medical License 2013 - 2025- American Board of Pathology Pathology - Clinical
Publications & Presentations
PubMed
- RNA Damage Responses in Cellular Homeostasis, Genome Stability, and Disease.Hani S Zaher, Nima Mosammaparast
Annual Review of Pathology. 2024-10-30 - 1 citationsASCC1 structures and bioinformatics reveal a novel helix-clasp-helix RNA-binding motif linked to a two-histidine phosphodiesterase.Naga Babu Chinnam, Roopa Thapar, Andrew S Arvai, Altaf H Sarker, Jennifer M Soll
The Journal of Biological Chemistry. 2024-06-01 - TCAF1 promotes TRPV2-mediated Carelease in response to cytosolic DNA to protect stressed replication forks.Lingzhen Kong, Chen Cheng, Abigael Cheruiyot, Jiayi Yuan, Yichan Yang
Nature Communications. 2024-05-30
Journal Articles
- RNA Ligase-like Domain in Activating Signal Cointegrator 1 Complex Subunit 1 (ASCC1) Regulates ASCC Complex Function During Alkylation DamageNima Mosammaparast, MD, The Journal of Biological Chemistry
Press Mentions
Experimental Drug Treatment Stops a Deadly Form of Lung Cancer in MiceSeptember 8th, 2022- Experimental Drug Treatment Stops a Deadly Form of Lung Cancer in Mice : ScienceAlertSeptember 7th, 2022
- Experimental Drug Treatment Stops a Deadly Form of Lung Cancer in MiceSeptember 7th, 2022
- Join now to see all
Grant Support
- A signaling pathway specific for alkylation damageNIH/NCI2019–2024
- Research Scholar AwardAmerican Cancer Society2019–2023
- Mechanism and regulation of the DNA alkylation damage responseNIH/NCI2015–2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
